National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
12Prescription circumstances—general
Start here
Get a plain-English read of 12
Turn the raw legal text into a practical explanation grounded in National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
12 Prescription circumstances—general
Chemotherapy drugs (1) A chemotherapy drug is a restricted drug if there are one or more circumstances codes mentioned in the column of the table in Part 1 of Schedule 1 headed “Circumstances” in relation to each chemotherapy pharmaceutical benefit that has the chemotherapy drug.
Note: Different chemotherapy pharmaceutical benefits having the same drug may have different circumstances codes. For the purposes of this subsection, it does not matter which circumstances code is mentioned.
(2) A chemotherapy prescription for a dose of a restricted drug may only be written in circumstances mentioned in the column of the table in Part 1 of Schedule 3 headed “Circumstances and Purposes” in relation to any of the circumstances codes that relate to chemotherapy pharmaceutical benefits that have the drug. Related pharmaceutical benefits (3) For the purposes of paragraphs 85(7)(a) and (b) of the Act, if a circumstances code is mentioned in the column of the table in Schedule 2 headed “Circumstances” in relation to a related pharmaceutical benefit: (a) the pharmaceutical benefit is a relevant pharmaceutical benefit for the purposes of section 88A of the Act; and (b) the circumstances mentioned in the column of the table in Part 1 of Schedule 3 headed “Circumstances and Purposes” in relation to the circumstances code are circumstances in which a prescription for a special arrangement supply of the pharmaceutical benefit may be written. Application of this section (4) This section applies in addition to section 13 of the Listing Instrument.